Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

X Paoletti

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
Pharmaceutical Statistics|July 10, 2018
A proposal for a new PhD level curriculum on quantitative methods for drug developmentT Jaki, A Gordon, P Forster, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 21, 2016
Randomized phase II trial comparing molecularly targeted therapy based on tumor molecular profiling versus conventional therapy in patients with refractory cancer: cross-over analysis from the SHIVA trialL Belin, M Kamal, C Mauborgne, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 28, 2015
REBECA: a phase I study of bevacizumab and whole-brain radiation therapy for the treatment of brain metastasis from solid tumoursC Lévy, D Allouache, J Lacroix, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 3, 2014
REBECA: a phase I study of bevacizumab and whole-brain radiation therapy for the treatment of brain metastasis from solid tumoursC Lévy, D Allouache, J Lacroix, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|October 14, 2015
[Not Available]Y Neuzillet, S Rebouissou, A De Reynies, et al.
British Journal of Cancer|April 26, 2014
Randomised proof-of-concept phase II trial comparing targeted therapy based on tumour molecular profiling vs conventional therapy in patients with refractory cancer: results of the feasibility part of the SHIVA trialC Le Tourneau, X Paoletti, N Servant, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Pharmaceutical Statistics|July 10, 2018
A proposal for a new PhD level curriculum on quantitative methods for drug developmentT Jaki, A Gordon, P Forster, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 21, 2016
Randomized phase II trial comparing molecularly targeted therapy based on tumor molecular profiling versus conventional therapy in patients with refractory cancer: cross-over analysis from the SHIVA trialL Belin, M Kamal, C Mauborgne, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 28, 2015
REBECA: a phase I study of bevacizumab and whole-brain radiation therapy for the treatment of brain metastasis from solid tumoursC Lévy, D Allouache, J Lacroix, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 3, 2014
REBECA: a phase I study of bevacizumab and whole-brain radiation therapy for the treatment of brain metastasis from solid tumoursC Lévy, D Allouache, J Lacroix, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|October 14, 2015
[Not Available]Y Neuzillet, S Rebouissou, A De Reynies, et al.
British Journal of Cancer|April 26, 2014
Randomised proof-of-concept phase II trial comparing targeted therapy based on tumour molecular profiling vs conventional therapy in patients with refractory cancer: results of the feasibility part of the SHIVA trialC Le Tourneau, X Paoletti, N Servant, et al.
Pageof 3